Roivant Sciences (ROIV) Research & Development (2020 - 2025)

Roivant Sciences has reported Research & Development for 6 years, with the latest figure at $165.4 million in Q4 2025.

• For the quarter ending Q4 2025, Research & Development rose 16.8% year-over-year to $165.4 million; the trailing twelve-month figure through Dec 2025 stood at $624.5 million (up 21.65% YoY), and the FY2026 full-year result was $681.8 million, up 23.87% from the prior year.
• Research & Development for Q4 2025 stood at $165.4 million, roughly flat from $164.6 million in the prior quarter.
• The five-year high for Research & Development was $165.4 million in Q4 2025, with the low at $78.5 million in Q2 2021.
• Historically, Research & Development has averaged $131.8 million across 5 years, with a median of $132.1 million in 2021.
• Annual changes were most pronounced in 2021 — Research & Development tumbled 32.1% — and 2022, when it surged 73.0%.
• Roivant Sciences' Research & Development stood at $137.3 million in 2021, then declined by 8.6% to $125.5 million in 2022, then decreased by 13.85% to $108.1 million in 2023, then jumped by 30.93% to $141.6 million in 2024, then advanced by 16.8% to $165.4 million in 2025.
• The last three Research & Development figures came in at $165.4 million (Q4 2025), $164.6 million (Q3 2025), and $152.9 million (Q2 2025), per Business Quant data.